Dexcom Inc (DXCM)

$70.33 -0.73 (-1.03%)
Market Cap 27.87B
Revenue (ttm) 4.03B
Net Income (ttm) 576.20M
EPS (ttm) N/A
PE Ratio 41.59
Forward PE 34.62
Profit Margin 14.29%
Debt to Equity Ratio 0.48
Volume 3,161,900
Avg Vol 5,103,210
Day's Range N/A - N/A
Shares Out 392.16M
Stochastic %K 80%
Beta 1.47
Analysts Strong Sell
Price Target $98.96

Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized thir...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 200 0200
Address:
6340 Sequence Drive, San Diego, United States
Mobagri
Mobagri Oct. 25 at 12:00 PM
$DXCM where is ckjamesst? Is he hibernating? He makes the thread more exciting.
0 · Reply
Typoon
Typoon Oct. 24 at 10:00 PM
$DXCM Monday will be our day!!
1 · Reply
Molllz_smartmoney
Molllz_smartmoney Oct. 24 at 5:50 PM
$DXCM trimming some here 🔥 Jan ‘26 75C ran from 4.50 → 5.88 Locking partials around 30% gains 💰 Never wrong taking profit — discipline is key 📊
0 · Reply
dlp02446
dlp02446 Oct. 24 at 4:46 PM
$DXCM I've told everyone, do the opposite of what that clown says and you'll come out ahead!
0 · Reply
Punpire
Punpire Oct. 24 at 3:14 PM
$DXCM No body knows where stocks are going including @Mobagri . His come back will be how $SENS is doing but I don't own any Sens at the moment. He's desperate to gain the losses he's had since Dexcom dropped from $130.
1 · Reply
Mobagri
Mobagri Oct. 24 at 2:20 PM
$DXCM last opportunity to make a quick buck. Going back to $90 November 1st
1 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 8:05 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $DXCM Current Share Price: $70.81 Contracts: $DXCM December 18, 2026 $75 Calls Scale in: $11.95- $14.60 Scale out: $18.58-$23.89 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 23 at 4:44 PM
$DXCM Current Stock Price: $70.67 Contracts to trade: $70 DXCM Oct 24 2025 Call Entry: $1.10 Exit: $1.53 ROI: 39% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
purdiestpam
purdiestpam Oct. 23 at 2:09 PM
$DXCM the volumes been so consistently low. Some good news will rocket this puppy
1 · Reply
Mobagri
Mobagri Oct. 23 at 12:59 PM
$DXCM most likely we hit $75 today
1 · Reply
Latest News on DXCM
10 stocks primed for growth in the S&P 500's cheapest sectors

Oct 23, 2025, 11:29 AM EDT - 1 day ago

10 stocks primed for growth in the S&P 500's cheapest sectors

BX AJG APO BRO FITB HOOD KKR

DexCom May Be The Most Underrated Growth Story In Healthcare

Oct 6, 2025, 6:39 AM EDT - 19 days ago

DexCom May Be The Most Underrated Growth Story In Healthcare

Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time.

Oct 2, 2025, 8:30 AM EDT - 22 days ago

Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time.

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Sep 18, 2025, 10:57 AM EDT - 5 weeks ago

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025

Sep 15, 2025, 3:15 AM EDT - 5 weeks ago

Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025

DexCom, Inc. (DXCM) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 10, 2025, 4:23 PM EDT - 6 weeks ago

DexCom, Inc. (DXCM) Presents At Baird Global Healthcare Conference 2025 Transcript

Dexcom Launches Its First Open Call to Uncover the Next Diabetes Advocates Ahead of World Diabetes Day

Sep 10, 2025, 8:30 AM EDT - 6 weeks ago

Dexcom Launches Its First Open Call to Uncover the Next Diabetes Advocates Ahead of World Diabetes Day

DexCom, Inc. (DXCM) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)

Sep 3, 2025, 4:53 PM EDT - 7 weeks ago

DexCom, Inc. (DXCM) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)

DexCom, GE, SLB: Why Experts Rate These Stocks at Strong Buy

Aug 28, 2025, 7:02 AM EDT - 2 months ago

DexCom, GE, SLB: Why Experts Rate These Stocks at Strong Buy

GE SLB

Dexcom Announces Upcoming Conference Presentations

Aug 26, 2025, 8:30 AM EDT - 2 months ago

Dexcom Announces Upcoming Conference Presentations

Dexcom's Arizona facility can service good portion of U.S. business, says CEO

Aug 5, 2025, 3:00 PM EDT - 2 months ago

Dexcom's Arizona facility can service good portion of U.S. business, says CEO

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

Jul 31, 2025, 9:52 AM EDT - 3 months ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH EW ISRG LLY PODD SYK

DexCom, Inc. (DXCM) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 8:58 PM EDT - 3 months ago

DexCom, Inc. (DXCM) Q2 2025 Earnings Call Transcript

Dexcom beats estimates for quarterly results, names new CEO

Jul 30, 2025, 5:23 PM EDT - 3 months ago

Dexcom beats estimates for quarterly results, names new CEO

Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan

Jul 30, 2025, 4:02 PM EDT - 3 months ago

Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan

Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program

Jul 30, 2025, 8:00 AM EDT - 3 months ago

Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program

Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio

Jul 28, 2025, 8:30 AM EDT - 3 months ago

Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio

Tenovi Expands Access to Glucose Data for Remote Patient Monitoring and Cardiometabolic Programs Through Dexcom Integration

Jul 23, 2025, 7:45 AM EDT - 3 months ago

Tenovi Expands Access to Glucose Data for Remote Patient Monitoring and Cardiometabolic Programs Through Dexcom Integration

DexCom: Delivering Consistent Growth

Jul 21, 2025, 11:26 AM EDT - 3 months ago

DexCom: Delivering Consistent Growth

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

Jul 21, 2025, 10:27 AM EDT - 3 months ago

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

CMG COF FSLR INTU LLY MA MPWR

Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews

Jul 17, 2025, 8:30 AM EDT - 3 months ago

Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews

Johnson Fistel Continues Investigation on Behalf of DexCom, Inc. Shareholders

Jul 9, 2025, 6:30 PM EDT - 3 months ago

Johnson Fistel Continues Investigation on Behalf of DexCom, Inc. Shareholders

The Best Growth Stocks to Buy

Jul 8, 2025, 8:12 AM EDT - 3 months ago

The Best Growth Stocks to Buy

ALGM AMZN AVGO BURL CTRE DAR GE

Dexcom Schedules Second Quarter 2025 Earnings Release and Conference Call for July 30, 2025 at 4:30 p.m. Eastern Time.

Jul 1, 2025, 8:30 AM EDT - 4 months ago

Dexcom Schedules Second Quarter 2025 Earnings Release and Conference Call for July 30, 2025 at 4:30 p.m. Eastern Time.

Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025

Jun 18, 2025, 8:30 AM EDT - 4 months ago

Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025

Jefferies' high conviction US stocks for the summer: Nvidia among top picks

Jun 4, 2025, 1:36 PM EDT - 5 months ago

Jefferies' high conviction US stocks for the summer: Nvidia among top picks

COF NVDA

Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO

May 13, 2025, 8:30 AM EDT - 5 months ago

Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO

DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure

May 9, 2025, 11:00 AM EDT - 6 months ago

DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure

DexCom: Growth Is Reaccelerating But Don't Ignore The Risks

May 5, 2025, 4:34 AM EDT - 6 months ago

DexCom: Growth Is Reaccelerating But Don't Ignore The Risks

Nasdaq Index: Dexcom, Meta, ON Semi Lead US Stocks Rebound on Trade Optimism

May 2, 2025, 1:43 PM EDT - 6 months ago

Nasdaq Index: Dexcom, Meta, ON Semi Lead US Stocks Rebound on Trade Optimism

META ON

Dexcom Stock Is Today's Big Winner After Earnings. Why the Medtech Is Soaring.

May 2, 2025, 11:53 AM EDT - 6 months ago

Dexcom Stock Is Today's Big Winner After Earnings. Why the Medtech Is Soaring.

DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript

May 1, 2025, 9:04 PM EDT - 6 months ago

DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript

Dexcom beats quarterly sales estimates, reiterates annual forecast

May 1, 2025, 4:54 PM EDT - 6 months ago

Dexcom beats quarterly sales estimates, reiterates annual forecast

Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program

May 1, 2025, 4:02 PM EDT - 6 months ago

Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom

Apr 30, 2025, 4:12 PM EDT - 6 months ago

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom

ABBV ABT GSK JNJ LLY MRK NVS

Healthy Returns: What drugmakers are saying about Trump's looming pharmaceutical tariffs

Apr 16, 2025, 12:51 PM EDT - 6 months ago

Healthy Returns: What drugmakers are saying about Trump's looming pharmaceutical tariffs

JNJ LLY

FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch

Apr 10, 2025, 1:28 PM EDT - 7 months ago

FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch

DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance

Apr 10, 2025, 11:34 AM EDT - 7 months ago

DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance

Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System

Apr 10, 2025, 8:30 AM EDT - 7 months ago

Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System

Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.

Apr 3, 2025, 8:30 AM EDT - 7 months ago

Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.

Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems

Apr 1, 2025, 8:00 AM EDT - 7 months ago

Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems

These 20 worst-performing stocks in the S&P 500 sank 17% or more in March

Mar 31, 2025, 5:02 PM EDT - 7 months ago

These 20 worst-performing stocks in the S&P 500 sank 17% or more in March

DAL BBY CCL CEG CZR DECK EPAM

Dexcom Appoints Jon Coleman as Chief Commercial Officer

Mar 25, 2025, 4:05 PM EDT - 7 months ago

Dexcom Appoints Jon Coleman as Chief Commercial Officer

Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom

Mar 25, 2025, 11:50 AM EDT - 7 months ago

Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care

Mar 19, 2025, 4:00 AM EDT - 7 months ago

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care

History Says Shut Up And Buy: 12 Hyper-Growth Blue Chips To Buy Right Now

Mar 14, 2025, 7:00 AM EDT - 8 months ago

History Says Shut Up And Buy: 12 Hyper-Growth Blue Chips To Buy Right Now

AMZN ASML BAM CGNX KFRC LCII MAN

Dexcom Appoints Renée Galá to Board of Directors

Mar 10, 2025, 8:30 AM EDT - 8 months ago

Dexcom Appoints Renée Galá to Board of Directors

Mobagri
Mobagri Oct. 25 at 12:00 PM
$DXCM where is ckjamesst? Is he hibernating? He makes the thread more exciting.
0 · Reply
Typoon
Typoon Oct. 24 at 10:00 PM
$DXCM Monday will be our day!!
1 · Reply
Molllz_smartmoney
Molllz_smartmoney Oct. 24 at 5:50 PM
$DXCM trimming some here 🔥 Jan ‘26 75C ran from 4.50 → 5.88 Locking partials around 30% gains 💰 Never wrong taking profit — discipline is key 📊
0 · Reply
dlp02446
dlp02446 Oct. 24 at 4:46 PM
$DXCM I've told everyone, do the opposite of what that clown says and you'll come out ahead!
0 · Reply
Punpire
Punpire Oct. 24 at 3:14 PM
$DXCM No body knows where stocks are going including @Mobagri . His come back will be how $SENS is doing but I don't own any Sens at the moment. He's desperate to gain the losses he's had since Dexcom dropped from $130.
1 · Reply
Mobagri
Mobagri Oct. 24 at 2:20 PM
$DXCM last opportunity to make a quick buck. Going back to $90 November 1st
1 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 8:05 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $DXCM Current Share Price: $70.81 Contracts: $DXCM December 18, 2026 $75 Calls Scale in: $11.95- $14.60 Scale out: $18.58-$23.89 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 23 at 4:44 PM
$DXCM Current Stock Price: $70.67 Contracts to trade: $70 DXCM Oct 24 2025 Call Entry: $1.10 Exit: $1.53 ROI: 39% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
purdiestpam
purdiestpam Oct. 23 at 2:09 PM
$DXCM the volumes been so consistently low. Some good news will rocket this puppy
1 · Reply
Mobagri
Mobagri Oct. 23 at 12:59 PM
$DXCM most likely we hit $75 today
1 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 23 at 10:51 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $DXCM Current Share Price: $70.70 Contracts: $DXCM December 18, 2026 $75 Calls Scale in: $12.22- $14.93 Scale out: $19.00-$24.43 Can Easily Capture: 60% ROI Blended DTE: 422 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
clan
clan Oct. 23 at 10:00 AM
$MNKD Will the new print & TV ads for Afrezza be released before, or after, 1/1/26? $DXCM #Rollout #ItsComing #NewCampaign #UpdatedDosing #ExpandedSalesForce
1 · Reply
purdiestpam
purdiestpam Oct. 22 at 9:35 PM
$DXCM will this chat not be active till earnings . Sheebs
0 · Reply
biostock
biostock Oct. 22 at 3:09 PM
$DXCM 102 Let's go $SPY $QQQ
0 · Reply
Mobagri
Mobagri Oct. 22 at 3:00 PM
$DXCM told you. Still not late to make a quick buck
0 · Reply
OptionRunners
OptionRunners Oct. 22 at 2:18 PM
$DXCM strong again. Calls still in the OI up to about $4.70 now with earnings next week.
0 · Reply
AlessandroValente
AlessandroValente Oct. 22 at 2:06 PM
$DXCM I'm dexcoming
0 · Reply
trading_insight
trading_insight Oct. 22 at 5:37 AM
Out of $DXCM for 30% close enough to $70 target 🤝
0 · Reply
Mobagri
Mobagri Oct. 22 at 2:37 AM
$DXCM https://www.investing.com/news/analyst-ratings/dexcom-stock-price-target-maintained-at-100-by-piper-sandler-93CH-4299226
0 · Reply
rangerhawkeye
rangerhawkeye Oct. 21 at 8:53 PM
$DXCM about time this moves
0 · Reply
Mobagri
Mobagri Oct. 21 at 6:41 PM
$DXCM next stop $75
0 · Reply
Mobagri
Mobagri Oct. 21 at 5:17 PM
$DXCM
1 · Reply